212 related articles for article (PubMed ID: 19689365)
1. Melanotropins as drugs for the treatment of obesity and other feeding disorders: potential and problems.
Cai M; Nyberg J; Hruby VJ
Curr Top Med Chem; 2009; 9(6):554-63. PubMed ID: 19689365
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of ligands selective for the melanocortin-3 receptor.
Hruby VJ; Cai M; Cain JP; Mayorov AV; Dedek MM; Trivedi D
Curr Top Med Chem; 2007; 7(11):1107-19. PubMed ID: 17584128
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Novel Potent and Selective Agonists at the Melanocortin-3 Receptor.
Carotenuto A; Merlino F; Cai M; Brancaccio D; Yousif AM; Novellino E; Hruby VJ; Grieco P
J Med Chem; 2015 Dec; 58(24):9773-8. PubMed ID: 26599352
[TBL] [Abstract][Full Text] [Related]
4. Extensive structure-activity studies of lactam derivatives of MT-II and SHU-9119: their activity and selectivity at human melanocortin receptors 3, 4, and 5.
Grieco P; Balse-Srinivasan P; Han G; Weinberg D; MacNeil T; Van der Ploeg LH; Hruby VJ
J Pept Res; 2003 Nov; 62(5):199-206. PubMed ID: 14531843
[TBL] [Abstract][Full Text] [Related]
5. A derivative of the melanocortin receptor antagonist SHU9119 (PG932) increases food intake when administered peripherally.
Sutton GM; Josephine Babin M; Gu X; Hruby VJ; Butler AA
Peptides; 2008 Jan; 29(1):104-11. PubMed ID: 18054119
[TBL] [Abstract][Full Text] [Related]
6. Melanocortins and agouti-related protein modulate the excitability of two arcuate nucleus neuron populations by alteration of resting potassium conductances.
Smith MA; Hisadome K; Al-Qassab H; Heffron H; Withers DJ; Ashford ML
J Physiol; 2007 Jan; 578(Pt 2):425-38. PubMed ID: 17068101
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-D-Phe-Arg-Trp-NH2 at the mouse melanocortin receptors. 4. Modifications at the Trp position.
Holder JR; Xiang Z; Bauzo RM; Haskell-Luevano C
J Med Chem; 2002 Dec; 45(26):5736-44. PubMed ID: 12477357
[TBL] [Abstract][Full Text] [Related]
8. Further structure-activity studies of lactam derivatives of MT-II and SHU-9119: their activity and selectivity at human melanocortin receptors 3, 4, and 5.
Grieco P; Cai M; Han G; Trivedi D; Campiglia P; Novellino E; Hruby VJ
Peptides; 2007 Jun; 28(6):1191-6. PubMed ID: 17482720
[TBL] [Abstract][Full Text] [Related]
9. Role of central melanocortin signaling in eating disorders.
Lu XY
Psychopharmacol Bull; 2001; 35(4):45-65. PubMed ID: 12397856
[TBL] [Abstract][Full Text] [Related]
10. Promising strategies for obesity pharmacotherapy: melanocortin-4 (MC-4) receptor agonists and melanin concentrating hormone (MCH) receptor-1 antagonists.
Jeon MK; Cheon HG
Curr Top Med Chem; 2009; 9(6):504-38. PubMed ID: 19689363
[TBL] [Abstract][Full Text] [Related]
11. The melanocortin pathway and control of appetite-progress and therapeutic implications.
Baldini G; Phelan KD
J Endocrinol; 2019 Apr; 241(1):R1-R33. PubMed ID: 30812013
[TBL] [Abstract][Full Text] [Related]
12. Melanocortin-4 receptor (MC4R) agonists for the treatment of obesity.
Nargund RP; Strack AM; Fong TM
J Med Chem; 2006 Jul; 49(14):4035-43. PubMed ID: 16821763
[No Abstract] [Full Text] [Related]
13. Synthesis, biophysical, and pharmacological evaluation of the melanocortin agonist AST3-88: modifications of peptide backbone at Trp 7 position lead to a potent, selective, and stable ligand of the melanocortin 4 receptor (MC4R).
Singh A; Dirain ML; Wilczynski A; Chen C; Gosnell BA; Levine AS; Edison AS; Haskell-Luevano C
ACS Chem Neurosci; 2014 Oct; 5(10):1020-31. PubMed ID: 25141170
[TBL] [Abstract][Full Text] [Related]
14. A novel and selective beta-melanocyte-stimulating hormone-derived peptide agonist for melanocortin 4 receptor potently decreased food intake and body weight gain in diet-induced obese rats.
Hsiung HM; Hertel J; Zhang XY; Smith DP; Smiley DL; Heiman ML; Yang DD; Husain S; Mayer JP; Zhang L; Mo H; Yan LZ
Endocrinology; 2005 Dec; 146(12):5257-66. PubMed ID: 16166226
[TBL] [Abstract][Full Text] [Related]
15. Melanocortin-4 Receptor Signalling: Importance for Weight Regulation and Obesity Treatment.
Kühnen P; Krude H; Biebermann H
Trends Mol Med; 2019 Feb; 25(2):136-148. PubMed ID: 30642682
[TBL] [Abstract][Full Text] [Related]
16. The Melanocortin Receptor System: A Target for Multiple Degenerative Diseases.
Cai M; Hruby VJ
Curr Protein Pept Sci; 2016; 17(5):488-96. PubMed ID: 26916163
[TBL] [Abstract][Full Text] [Related]
17. The role of melanocortins in body weight regulation: opportunities for the treatment of obesity.
MacNeil DJ; Howard AD; Guan X; Fong TM; Nargund RP; Bednarek MA; Goulet MT; Weinberg DH; Strack AM; Marsh DJ; Chen HY; Shen CP; Chen AS; Rosenblum CI; MacNeil T; Tota M; MacIntyre ED; Van der Ploeg LH
Eur J Pharmacol; 2002 Aug; 450(1):93-109. PubMed ID: 12176114
[TBL] [Abstract][Full Text] [Related]
18. The role of melanocortins in body weight regulation: opportunities for the treatment of obesity.
MacNeil DJ; Howard AD; Guan X; Fong TM; Nargund RP; Bednarek MA; Goulet MT; Weinberg DH; Strack AM; Marsh DJ; Chen HY; Shen CP; Chen AS; Rosenblum CI; MacNeil T; Tota M; MacIntyre ED; Van der Ploeg LH
Eur J Pharmacol; 2002 Apr; 440(2-3):141-57. PubMed ID: 12007532
[TBL] [Abstract][Full Text] [Related]
19. Regulation of adipose tissue leptin secretion by alpha-melanocyte-stimulating hormone and agouti-related protein: further evidence of an interaction between leptin and the melanocortin signalling system.
Hoggard N; Hunter L; Duncan JS; Rayner DV
J Mol Endocrinol; 2004 Feb; 32(1):145-53. PubMed ID: 14765998
[TBL] [Abstract][Full Text] [Related]
20. Exploring the stereostructural requirements of peptide ligands for the melanocortin receptors.
Hruby VJ; Cai M; Grieco P; Han G; Kavarana M; Trivedi D
Ann N Y Acad Sci; 2003 Jun; 994():12-20. PubMed ID: 12851293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
